These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 31189013

  • 21. A 20-Year Temporal Change Analysis in Incidence, Presenting Phenotype and Mortality, in the Dutch IBDSL Cohort-Can Diagnostic Factors Explain the Increase in IBD Incidence?
    van den Heuvel TRA, Jeuring SFG, Zeegers MP, van Dongen DHE, Wolters A, Masclee AAM, Hameeteman WH, Romberg-Camps MJL, Oostenbrug LE, Pierik MJ, Jonkers DM.
    J Crohns Colitis; 2017 Oct 01; 11(10):1169-1179. PubMed ID: 28430884
    [Abstract] [Full Text] [Related]

  • 22. Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden.
    Axelrad JE, Olén O, Sachs MC, Erichsen R, Pedersen L, Halfvarson J, Askling J, Ekbom A, Sørensen HT, Ludvigsson JF.
    Gut; 2021 Feb 01; 70(2):297-308. PubMed ID: 32474410
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Kristensen MS, Kjærulff TM, Ersbøll AK, Green A, Hallas J, Thygesen LC.
    Inflamm Bowel Dis; 2019 Apr 11; 25(5):886-893. PubMed ID: 30551218
    [Abstract] [Full Text] [Related]

  • 25. Severe COVID-19 in inflammatory bowel disease patients in a population-based setting.
    Creemers RH, Rezazadeh Ardabili A, Jonkers DM, Leers MPG, Romberg-Camps MJ, Pierik MJ, van Bodegraven AA.
    PLoS One; 2021 Apr 11; 16(10):e0258271. PubMed ID: 34610041
    [Abstract] [Full Text] [Related]

  • 26. Inflammatory bowel disease and risk of severe COVID-19: A nationwide population-based cohort study in Sweden.
    Ludvigsson JF, Axelrad J, Halfvarson J, Khalili H, Larsson E, Lochhead P, Roelstraete B, Simon TG, Söderling J, Olén O.
    United European Gastroenterol J; 2021 Mar 11; 9(2):177-192. PubMed ID: 33704918
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cause-specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitis.
    Selinger CP, Andrews J, Dent OF, Norton I, Jones B, McDonald C, Cowlishaw J, Barr G, Selby W, Leong RW, Sydney IBD Cohort Study Group.
    Inflamm Bowel Dis; 2013 Aug 11; 19(9):1880-8. PubMed ID: 23765177
    [Abstract] [Full Text] [Related]

  • 30. Descriptive epidemiology of children hospitalized for inflammatory bowel disease in Japan: Inpatient database analysis.
    Takeuchi M, Tomomasa T, Yasunaga H, Horiguchi H, Fushimi K.
    Pediatr Int; 2015 Jun 11; 57(3):443-8. PubMed ID: 25442802
    [Abstract] [Full Text] [Related]

  • 31. Inflammatory Bowel Disease and Risk of Colorectal Polyps: A Nationwide Population-Based Cohort Study From Sweden.
    Axelrad JE, Olén O, Söderling J, Roelstraete B, Khalili H, Song M, Faye A, Eberhardson M, Halfvarson J, Ludvigsson JF.
    J Crohns Colitis; 2023 Oct 20; 17(9):1395-1409. PubMed ID: 36994851
    [Abstract] [Full Text] [Related]

  • 32. Epidemiology of inflammatory bowel disease in Québec: recent trends.
    Bitton A, Vutcovici M, Patenaude V, Sewitch M, Suissa S, Brassard P.
    Inflamm Bowel Dis; 2014 Oct 20; 20(10):1770-6. PubMed ID: 25159452
    [Abstract] [Full Text] [Related]

  • 33. The Faroese IBD Study: Incidence of Inflammatory Bowel Diseases Across 54 Years of Population-based Data.
    Hammer T, Nielsen KR, Munkholm P, Burisch J, Lynge E.
    J Crohns Colitis; 2016 Aug 20; 10(8):934-42. PubMed ID: 26933031
    [Abstract] [Full Text] [Related]

  • 34. Risk of malignancy in a high-incidence population-based cohort of Faroese patients with inflammatory bowel disease from 1960 to 2020 - a Faroese IBD cohort study.
    Midjord J, Nielsen KR, Vang AG, Strøm M, Lophaven S, Hammer T, Burisch J.
    Scand J Gastroenterol; 2024 Jun 20; 59(6):661-668. PubMed ID: 38407208
    [Abstract] [Full Text] [Related]

  • 35. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
    Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, Nørregaard P, Moesgaard F, Bendtsen F, Munkholm P, DCCD study group.
    Am J Gastroenterol; 2006 Jun 20; 101(6):1274-82. PubMed ID: 16771949
    [Abstract] [Full Text] [Related]

  • 36. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004.
    Jess T, Loftus EV, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ, Munkholm P, Sandborn WJ.
    Gut; 2006 Sep 20; 55(9):1248-54. PubMed ID: 16423890
    [Abstract] [Full Text] [Related]

  • 37. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.
    Nguyen GC, Sam J.
    Am J Gastroenterol; 2008 Sep 20; 103(9):2272-80. PubMed ID: 18684186
    [Abstract] [Full Text] [Related]

  • 38. Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea.
    Chang K, Lee HS, Kim YJ, Kim SO, Kim SH, Lee SH, Song EM, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK.
    Clin Gastroenterol Hepatol; 2018 Dec 20; 16(12):1928-1936.e2. PubMed ID: 29857150
    [Abstract] [Full Text] [Related]

  • 39. Prevalence, incidence and mortality of inflammatory bowel disease in Catalonia. A population-based analysis.
    Brunet E, Roig-Ramos C, Vela E, Clèries M, Melcarne L, Villòria A, Pontes C, Calvet X.
    Ann Med; 2018 Nov 20; 50(7):613-619. PubMed ID: 30247071
    [Abstract] [Full Text] [Related]

  • 40. Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
    Korzenik J, Larsen MD, Nielsen J, Kjeldsen J, Nørgård BM.
    Aliment Pharmacol Ther; 2019 Aug 20; 50(3):289-294. PubMed ID: 31267570
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.